Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Grommit who wrote (51315)	4/16/2013 3:16:25 PM
From: CusterInvestor	Respond to of 78752

FCX is tempting, but waiting to see if it holds the low today---right on the fence at this moment.

To: Grommit who wrote (51315)	5/24/2013 11:45:37 AM
From: E_K_S	Respond to of 78752

Covidien plc(NYSE:COV Covidien to Issue 8 Mallinckrodt Shares for Each Covidien Share in Spinoff Covidien PLC's (COV) board approved the spinoff of its pharmaceuticals business and set an exchange ratio of eight Mallinckrodt PLC shares for each Covidien share.Covidien--a maker of operating-room gear, generic drugs and other medical supplies--said it expects the distribution to occur on June 28 for shareholders of record as of June 19.Trading of Mallinckrodt shares is expected to begin July 1 on the New York Stock Exchange under the symbol MNK. The spin off of their pharma division should bring more value to the company. Missed the recent buy as I owned this one early last year but sold it on the run up. EKS